Clinical Trials Logo

Varicose Ulcer clinical trials

View clinical trials related to Varicose Ulcer.

Filter by:

NCT ID: NCT05805137 Recruiting - Venous Ulcer Clinical Trials

Monitoring of Venous Ulcers Using a Bioimpedance Measurement Based Method and System

WoundWatchâ„¢
Start date: April 20, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the functionality of a new type of wound monitoring method and measurement system for monitoring healing of venous ulcers. The system is consisted of a wound dressing with electrodes (eDressing), a bioimpedance measurement device and a mobile phone application.

NCT ID: NCT05772507 Recruiting - Diabetic Foot Ulcer Clinical Trials

Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings (EXPANSION)

Start date: August 22, 2023
Phase: N/A
Study type: Interventional

Evaluation of the efficacy (wound epithelialization and time to closure) and tolerance (emergence and nature of adverse event) of the new URGO AWC_008 and URGO AWC_022 dressings in local management of acute and chronic wounds at risk of local infection or with clinical signs of local infection

NCT ID: NCT05633277 Recruiting - Clinical trials for Venous Insufficiency

Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections

Start date: September 30, 2020
Phase: N/A
Study type: Interventional

Randomized Controlled Trial to determine if the outcomes of sclerotherapy of the ulcer bed alone differ from a combination of ablation and sclerotherapy injections.

NCT ID: NCT05608317 Recruiting - Venous Leg Ulcer Clinical Trials

A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing

Start date: November 8, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial to follow the progress of wounds in those with chronic venous leg ulcers while using a non-bordered foam dressing. The main objective is to follow the progress of these wounds over time from initial visit to each follow-up visit. Participants will be asked to wear the dressing for up to 6 weeks of treatment or until healed, changed at every one-week interval.

NCT ID: NCT05588583 Recruiting - Diabetic Foot Ulcer Clinical Trials

A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Start date: October 31, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to follow the progress of wounds in those with venous leg ulcers and diabetic foot ulcers while using an absorbent dressing called Mepilex Up. The main objective is to follow the progress of these wounds over time from initial visit to each follow-up visit. Participants will be asked to wear Mepilex Up dressing for up to 6 weeks of treatment or until healed, changed at every one-week interval.

NCT ID: NCT05570877 Recruiting - Diabetic Foot Ulcer Clinical Trials

ChitoCare Medical Wound Healing Gel PMCF Study on Healing of Chronic Wounds

CHITOCHRONIC
Start date: January 11, 2022
Phase: N/A
Study type: Interventional

The purpose of this PMCF study is to evaluate the safety and efficacy of ChitoCare medical Wound Healing Gel for the healing of chronic wounds. The study will enroll patients with diabetic foot ulcer, venous ulcer or pressure ulcer. Patients will be randomly assigned to an active or control group. The active group will apply the gel to the wound, in addition to the standard of care, while the control group will receive only standard care. The study will last from 3 to 18 months for an individual patient (15-month recruitment period and 3 months of follow-up after the last patient is enrolled) or until event occurrence (complete wound healing/exclusion from the study). The study envisages four visits: Visit 1 - Screening and Inclusion visit, Visit 2 (after 4 weeks), Visit 3 (after 12 weeks) and Visit 4 - End of Study Visit: The final visit will take place when the event occurs (complete healing/exclusion from study). On each visit, the patients will have their wound photographed and assessed after debridement. Adverse events will be followed throughout the whole study.

NCT ID: NCT05549609 Recruiting - Venous Leg Ulcer Clinical Trials

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers

Start date: October 26, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of the study is to assess safety, tolerability and preliminary efficacy of XSTEM-VLU when administered as a single topical dose to patients with difficult-to-heal venous leg ulcers. The study is randomised and the patients will receive either XSTEM-VLU or vehicle as add on to standard wound care. The patients will be followed weekly for 10 weeks after treatment. At 4 months after treatment, the patients will return to the clinic for an end-of-study visit.

NCT ID: NCT05489588 Recruiting - Venous Leg Ulcer Clinical Trials

The GORE® VIAFORT Vascular Stent Iliofemoral Study

Start date: March 2, 2023
Phase: N/A
Study type: Interventional

This study is a prospective, non-randomized, multicenter, single-arm, clinical study to evaluate the performance, safety and efficacy of the GORE® VIAFORT Vascular Stent for treatment of symptomatic iliofemoral venous obstruction.

NCT ID: NCT05410613 Recruiting - Venous Leg Ulcer Clinical Trials

Combined Electromagnetic Field and a Plantar Resistance Exercise With Venous Leg Ulcer

Start date: January 20, 2022
Phase: N/A
Study type: Interventional

The purpose of this study will investigate the effects of combined electromagnetic field and a plantar resistance exercise therapy versus electromagnetic field on healing of venous leg ulcer .

NCT ID: NCT05409976 Recruiting - Venous Leg Ulcer Clinical Trials

The GORE® VIAFORT Vascular Stent IVC Study

Start date: October 25, 2022
Phase: N/A
Study type: Interventional

This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIAFORT Vascular Stent for treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction in adult patients.